Incidence of liver toxicity in hiv-infected patients receiving isolated dual nucleoside analogue antitretroviral therapy.
Verucchi
Gabriella
G
Calza
Leonardo
L
Manfredi
Roberto
R
Chiodo
Francesco
F
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D015994:Incidence; D008099:Liver / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D018119:Stavudine / Q000009:adverse effects
D019380:Anti-HIV Agents; D018119:Stavudine; D000410:Alanine Transaminase; D016049:Didanosine